80 related articles for article (PubMed ID: 34154626)
1. RNA-binding protein IMP3 is a novel regulator of MEK1/ERK signaling pathway in the progression of colorectal Cancer through the stabilization of MEKK1 mRNA.
Zhang M; Zhao S; Tan C; Gu Y; He X; Du X; Li D; Wei P
J Exp Clin Cancer Res; 2021 Jun; 40(1):200. PubMed ID: 34154626
[TBL] [Abstract][Full Text] [Related]
2.
Wang K; Chu Y; Zhang H; Qu X; Wang B; Han Y
Comb Chem High Throughput Screen; 2024; 27(3):436-445. PubMed ID: 37151068
[TBL] [Abstract][Full Text] [Related]
3. Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
[TBL] [Abstract][Full Text] [Related]
4. Role of MEK1 and DIAPH3 expression in colorectal adenoma-carcinoma sequence.
Foda AAM; El-Hawary AK; Elnaghi K; Eldehna WM; Enan ET
Tumour Biol; 2024; 46(1):1-11. PubMed ID: 38728194
[TBL] [Abstract][Full Text] [Related]
5. The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression.
Jin H; Huang X; Pan Q; Ma N; Xie X; Wei Y; Yu F; Wen W; Zhang B; Zhang P; Chen X; Wang J; Liu RY; Lin J; Meng X; Lee MH
Nat Commun; 2024 Mar; 15(1):2551. PubMed ID: 38514606
[TBL] [Abstract][Full Text] [Related]
6. NOX4 promotes tumor progression through the MAPK-MEK1/2-ERK1/2 axis in colorectal cancer.
Xu YJ; Huo YC; Zhao QT; Liu JY; Tian YJ; Yang LL; Zhang Y
World J Gastrointest Oncol; 2024 Apr; 16(4):1421-1436. PubMed ID: 38660653
[TBL] [Abstract][Full Text] [Related]
7. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.
Zou S; Huang Y; Yang Z; Zhang J; Meng M; Zhang Y; Feng J; Sun R; Li W; Wang W; López JG; Fang L
Clin Transl Med; 2024 Mar; 14(3):e1621. PubMed ID: 38468490
[TBL] [Abstract][Full Text] [Related]
8. Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells.
Jürchott K; Kuban RJ; Krech T; Blüthgen N; Stein U; Walther W; Friese C; Kiełbasa SM; Ungethüm U; Lund P; Knösel T; Kemmner W; Morkel M; Fritzmann J; Schlag PM; Birchmeier W; Krueger T; Sperling S; Sers C; Royer HD; Herzel H; Schäfer R
PLoS Genet; 2010 Dec; 6(12):e1001231. PubMed ID: 21170361
[TBL] [Abstract][Full Text] [Related]
9. A case of class 3
Wang C; Sandhu J; Fakih M
J Gastrointest Oncol; 2019 Dec; 10(6):1140-1143. PubMed ID: 31949931
[TBL] [Abstract][Full Text] [Related]
10. PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1.
Yuan M; Zhang C; Chen S; Ye S; Liu H; Ke H; Huang J; Liang G; Yu R; Hu T; Wu X; Lan P
Cancer Lett; 2024 Jun; 597():217007. PubMed ID: 38849010
[TBL] [Abstract][Full Text] [Related]
11. ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework.
Timofeev O; Giron P; Lawo S; Pichler M; Noeparast M
NPJ Precis Oncol; 2024 Mar; 8(1):70. PubMed ID: 38485987
[TBL] [Abstract][Full Text] [Related]
12. Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine.
Zhang Y; Yu H; Zhang J; Gao H; Wang S; Li S; Wei P; Liang J; Yu G; Wang X; Li X; Li D; Yang W
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720086
[TBL] [Abstract][Full Text] [Related]
13. Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis.
Guo Y; Guo Y; Chen C; Fan D; Wu X; Zhao L; Shao B; Sun Z; Ji Z
Mol Cancer; 2021 Jun; 20(1):93. PubMed ID: 34172072
[TBL] [Abstract][Full Text] [Related]
14. IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.
Klingbeil KD; Tang JP; Graham DS; Lofftus SY; Jaiswal AK; Lin TL; Frias C; Chen LY; Nakasaki M; Dry SM; Crompton JG; Eilber FC; Rao DS; Kalbasi A; Kadera BE
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760460
[TBL] [Abstract][Full Text] [Related]
15. IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8
Ma L; Jiang J; Si Q; Chen C; Duan Z
J Clin Transl Hepatol; 2023 Nov; 11(6):1308-1320. PubMed ID: 37719968
[TBL] [Abstract][Full Text] [Related]
16. Targeting IGF2BP3 in Cancer.
Liu X; Chen J; Chen W; Xu Y; Shen Y; Xu X
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298373
[TBL] [Abstract][Full Text] [Related]
17. A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer.
Di Fusco D; Di Grazia A; Di Maggio G; Segreto MT; Iannucci A; Maresca C; De Stefano A; Sica G; Stolfi C; Monteleone G; Monteleone I
Cell Death Dis; 2023 Apr; 14(4):243. PubMed ID: 37024466
[TBL] [Abstract][Full Text] [Related]
18. The Expression of Insulin-Like Growth Factor II Messenger RNA-Binding Protein 3 Upregulated in Intradural Extramedullary Schwannomas.
Bekki H; Matsumoto Y; Yoshimoto M; Ishihara S; Kawaguchi K; Yamamoto H; Oda Y; Nakashima Y; Harimaya K
Spine Surg Relat Res; 2023 Jan; 7(1):36-41. PubMed ID: 36819630
[TBL] [Abstract][Full Text] [Related]
19. Spatially resolved transcriptomics revealed local invasion-related genes in colorectal cancer.
Liu HT; Chen SY; Peng LL; Zhong L; Zhou L; Liao SQ; Chen ZJ; Wang QL; He S; Zhou ZH
Front Oncol; 2023; 13():1089090. PubMed ID: 36816947
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.
Němejcová K; Bártů MK; Michálková R; Drozenová J; Fabian P; Fadare O; Hausnerová J; Laco J; Matěj R; Méhes G; Singh N; Stolnicu S; Škapa P; Švajdler M; Stružinská I; Cibula D; Kocian R; Lax SF; McCluggage WG; Dundr P
Diagn Pathol; 2023 Feb; 18(1):15. PubMed ID: 36740684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
